United States Pharmaceuticals

Verrica Pharmaceuticals Inc (VRCA)

Track

Verrica Pharmaceuticals Inc. experienced significant insider activity on November 25, 2025, when multiple executives and stakeholders executed substantial share purchases. These acquisitions represent the most recent trading events for the firm, marking a notable shift toward accumulation by leadership following earlier divestment patterns observed during the previous year.
Ticker: VRCA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Verrica Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 25 Nov 2025
Value US$1,168,766.57 | Price 321.70 | Shares 573 (+16.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-25 B Purchase
Zawitz David

Chief Operating Officer

Officer
573 +16.4%
321.70
US$1,168,767 		573 +16.4% 321.70 US$1,168,767
2025-11-25 2025-11-25 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
36,883 +31.1%
82.18
US$4,461,502 		36,883 +31.1% 82.18 US$4,461,502
2025-11-25 2025-11-25 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
74,113 -24.4%
499.08
US$937,217 		74,113 -24.4% 499.08 US$937,217
2025-11-25 2025-11-25 B Purchase
Rieger Jayson

CEO and President

Executive Director
94,311 +106.8%
4.24
US$400,114 		94,311 +106.8% 4.24 US$400,114
2025-11-25 2025-11-25 B Purchase
1.4
Kirby John J.

Interim CFO

Officer
3,536 +65.2%
4.24
US$15,001 		3,536 +65.2% 4.24 US$15,001
2025-11-25 2025-11-25 B Purchase
1.7
Rosenberg Noah L.

CMO

Officer
2,357 +inf%
4.24
US$10,000 		2,357 +inf% 4.24 US$10,000
2025-03-18 2025-03-17 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
4,315 -2.4%
0.65
US$2,805 		4,315 -2.4% 0.65 US$2,805
2024-08-28 2024-08-27 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
7,899 -15.0%
2.46
US$19,432 		7,899 -15.0% 2.46 US$19,432
2024-08-28 2024-08-27 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,601 -3.7%
2.46
US$8,858 		3,601 -3.7% 2.46 US$8,858
2024-08-28 2024-08-27 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
9,021 -4.0%
2.46
US$22,192 		9,021 -4.0% 2.46 US$22,192
2024-08-28 2024-08-27 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
9,530 -8.3%
2.46
US$23,444 		9,530 -8.3% 2.46 US$23,444
2024-08-28 2024-08-27 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
8,993 -11.0%
2.46
US$22,123 		8,993 -11.0% 2.46 US$22,123
2024-08-28 2024-08-26 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
21,820 -29.3%
2.66
US$58,041 		21,820 -29.3% 2.66 US$58,041
2024-08-28 2024-08-26 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
9,888 -9.2%
2.66
US$26,302 		9,888 -9.2% 2.66 US$26,302
2024-08-28 2024-08-26 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
24,979 -10.0%
2.66
US$66,444 		24,979 -10.0% 2.66 US$66,444
2024-08-28 2024-08-26 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
26,183 -18.5%
2.66
US$69,647 		26,183 -18.5% 2.66 US$69,647
2024-08-28 2024-08-26 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
24,709 -23.1%
2.66
US$65,726 		24,709 -23.1% 2.66 US$65,726
2024-08-26 2024-08-26 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
36,000
2.62
US$94,300 		36,000 2.62 US$94,300
2024-08-26 2024-08-26 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
14,000
2.64
US$37,000 		14,000 2.64 US$37,000
2024-08-26 2024-08-26 PrS Proposed sale
3.2
White Ted

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
30,000
2.65
US$79,500 		30,000 2.65 US$79,500
2024-07-23 2024-07-23 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
86 -0.1%
6.98
US$600 		86 -0.1% 6.98 US$600
2024-07-23 2024-07-23 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
115 -0.1%
6.98
US$803 		115 -0.1% 6.98 US$803
2024-07-23 2024-07-23 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
91 -0.1%
6.98
US$635 		91 -0.1% 6.98 US$635
2024-07-23 2024-07-23 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
154 -0.1%
6.98
US$1,075 		154 -0.1% 6.98 US$1,075
2024-07-23 2024-07-22 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
18,421 -14.6%
7.06
US$130,052 		18,421 -14.6% 7.06 US$130,052
2024-07-23 2024-07-22 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
25,461 -19.2%
7.06
US$179,755 		25,461 -19.2% 7.06 US$179,755
2024-07-23 2024-07-22 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
21,649 -13.3%
7.06
US$152,842 		21,649 -13.3% 7.06 US$152,842
2024-07-23 2024-07-22 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
32,469 -11.5%
7.06
US$229,231 		32,469 -11.5% 7.06 US$229,231
2024-07-22 2024-07-22 PrS Proposed sale
3.2
White Ted

Officer

Officer
32,953
6.97
US$229,628 		32,953 6.97 US$229,628
2024-07-22 2024-07-22 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
18,695
6.97
US$130,253 		18,695 6.97 US$130,253
2024-07-22 2024-07-22 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
21,971
6.97
US$153,085 		21,971 6.97 US$153,085
2024-07-22 2024-07-22 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
25,840
6.97
US$180,048 		25,840 6.97 US$180,048
2023-12-29 2023-12-29 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
115,774 +1.7%
7.24
US$838,204 		115,774 +1.7% 7.24 US$838,204
2023-12-29 2023-12-28 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
126,116 +1.8%
7.08
US$892,901 		126,116 +1.8% 7.08 US$892,901
2023-12-29 2023-12-27 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
79,726 +1.2%
7.20
US$574,027 		79,726 +1.2% 7.20 US$574,027
2023-12-26 2023-12-26 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
54,652 +0.8%
6.49
US$354,691 		54,652 +0.8% 6.49 US$354,691
2023-12-26 2023-12-22 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
250,000 +3.9%
6.67
US$1,667,500 		250,000 +3.9% 6.67 US$1,667,500
2023-12-26 2023-12-21 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
200,000 +3.2%
6.17
US$1,234,000 		200,000 +3.2% 6.17 US$1,234,000
2023-12-19 2023-12-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
277,008 +4.6%
5.36
US$1,484,763 		277,008 +4.6% 5.36 US$1,484,763
2023-12-19 2023-12-18 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
456,923 +8.2%
5.41
US$2,471,953 		456,923 +8.2% 5.41 US$2,471,953
2023-12-19 2023-12-15 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
500,000 +9.9%
5.97
US$2,985,000 		500,000 +9.9% 5.97 US$2,985,000
2023-11-16 2023-11-15 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
11,266 -10.9%
2.97
US$33,460 		11,266 -10.9% 2.97 US$33,460
2023-11-16 2023-11-15 S Sale
3.2
White Ted

President and CEO

Executive Director
11,558 -6.4%
2.97
US$34,327 		11,558 -6.4% 2.97 US$34,327
2023-11-16 2023-11-15 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
9,632 -21.9%
2.97
US$28,607 		9,632 -21.9% 2.97 US$28,607
2023-11-16 2023-11-15 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,036 -3.4%
2.97
US$9,017 		3,036 -3.4% 2.97 US$9,017
2023-11-16 2023-11-15 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
11,558 -8.6%
2.97
US$34,327 		11,558 -8.6% 2.97 US$34,327
2023-11-16 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-11-16 2023-11-14 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
21,580 -17.2%
2.93
US$63,229 		21,580 -17.2% 2.93 US$63,229
2023-11-16 2023-11-14 S Sale
3.2
White Ted

President and CEO

Executive Director
22,141 -10.9%
2.93
US$64,873 		22,141 -10.9% 2.93 US$64,873
2023-11-16 2023-11-14 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
18,452 -29.5%
2.93
US$54,064 		18,452 -29.5% 2.93 US$54,064
2023-11-16 2023-11-14 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
5,817 -6.1%
2.93
US$17,044 		5,817 -6.1% 2.93 US$17,044
2023-11-16 2023-11-14 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
22,141 -14.1%
2.93
US$64,873 		22,141 -14.1% 2.93 US$64,873
2023-11-15 2023-11-14 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
28,167
2.93
US$82,529 		28,167 2.93 US$82,529
2023-11-15 2023-11-14 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
8,879
2.93
US$26,015 		8,879 2.93 US$26,015
2023-11-15 2023-11-14 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-07-27 2023-07-24 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
28,699
4.80
US$137,837 		28,699 4.80 US$137,837
2023-07-27 2023-07-24 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
50,677
4.80
US$243,398 		50,677 4.80 US$243,398
2023-07-27 2023-07-24 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,789
4.80
US$162,285 		33,789 4.80 US$162,285
2023-07-27 2023-07-24 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
38,262
4.80
US$183,769 		38,262 4.80 US$183,769
2023-07-25 2023-07-24 S Sale
3.2
White Ted

President and CEO

Executive Director
50,677 -28.2%
4.83
US$244,770 		50,677 -28.2% 4.83 US$244,770
2023-07-25 2023-07-24 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
28,699 -29.0%
4.83
US$138,616 		28,699 -29.0% 4.83 US$138,616
2023-07-25 2023-07-24 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
38,262 -37.9%
4.83
US$184,805 		38,262 -37.9% 4.83 US$184,805
2023-07-25 2023-07-24 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
33,789 -29.2%
4.83
US$163,201 		33,789 -29.2% 4.83 US$163,201
2023-07-24 2023-07-24 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
200,000 +2.6%
5.02
US$1,004,000 		200,000 +2.6% 5.02 US$1,004,000
2022-07-11 2022-07-11 B Purchase
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
7,500 +91.3%
3.40
US$25,500 		7,500 +91.3% 3.40 US$25,500
2022-07-05 2022-07-05 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
4,761,904 +53.6%
2.10
US$9,999,998 		4,761,904 +53.6% 2.10 US$9,999,998
2022-07-05 2022-07-05 B Purchase
3.5
Goldenberg Gary

Chief Medical Officer

Officer
23,809 +inf%
2.10
US$49,999 		23,809 +inf% 2.10 US$49,999
2022-07-05 2022-07-05 B Purchase
3.9
Stalfort John A III
Non-Executive Director
238,095 +51.5%
2.10
US$500,000 		238,095 +51.5% 2.10 US$500,000
2022-07-05 2022-07-05 B Purchase
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
5,714 +228.6%
2.10
US$11,999 		5,714 +228.6% 2.10 US$11,999
2022-07-05 2022-07-05 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,428,571 +39.6%
2.10
US$2,999,999 		1,428,571 +39.6% 2.10 US$2,999,999
2022-07-05 2022-07-05 B Purchase
3.2
White Ted

President and CEO

Executive Director
23,809 +420.9%
2.10
US$49,999 		23,809 +420.9% 2.10 US$49,999
Explore more

More insider trading research around Verrica Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America